Candel Therapeutics Balance Sheet
NASDAQ: CADLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Candel Therapeutics financial position
At the end of fiscal 2025, Candel Therapeutics reported total assets of $125.2 million, up 17.2% from a year earlier against total liabilities of $73.3 million. Shareholders' equity stood at $51.9 million, or 41.5% of assets. The company held $119.7 million in cash and equivalents against $1.0 million of debt, a net cash position of $118.7 million.
The current ratio (current assets divided by current liabilities) was 13.49, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.02.
Summary generated from market data by MetaCap's automated system. Methodology
Candel Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 119.73M | 102.65M | 35.41M | 70.06M | 82.64M | 35.05M |
| Total Current Assets | 121.39M | 103.80M | 36.80M | 71.94M | 84.94M | 35.15M |
| Property, Plant & Equipment | 1.64M | 2.19M | 3.21M | 4.42M | 3.84M | 2.79M |
| Total Assets | 125.19M | 106.87M | 41.20M | 77.69M | 89.20M | 38.28M |
| Accounts Payable | 1.13M | 237.00K | 422.00K | 380.00K | 1.59M | 921.00K |
| Short-Term Debt | 0 | 9.89M | 8.89M | — | — | — |
| Total Current Liabilities | 9.00M | 37.53M | 14.18M | 5.62M | 5.36M | 4.71M |
| Long-Term Debt | 1.01M | 1.73M | 11.63M | 648.00K | 560.00K | 483.00K |
| Total Liabilities | 73.27M | 40.54M | 28.46M | 29.98M | 25.07M | 12.78M |
| Shareholders' Equity | 51.92M | 66.33M | 12.74M | 47.71M | 64.14M | -23.56M |
| Retained Earnings | -230.39M | -192.21M | -137.03M | -99.09M | -80.30M | -44.17M |
| Total Debt | 1.01M | 11.63M | 20.52M | 648.00K | 560.00K | 483.00K |
| Net Cash (Debt) | 118.72M | 91.03M | 14.89M | 69.41M | 82.08M | 34.57M |
| Shares Outstanding | 54.90M | 46.81M | 29.09M | 28.92M | 28.69M | 11.64M |
This table shows 6 annual periods of Candel Therapeutics's balance sheet, from FY 2025 back to FY 2020, across 14 line items including cash & equivalents, total current assets, property, plant & equipment. Values in USD; B = billions, M = millions. Fiscal periods follow CADL's reporting calendar. What is a balance sheet?